The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

被引:0
|
作者
Tea Rosic
Raveena Kapoor
Balpreet Panesar
Leen Naji
Darren B. Chai
Nitika Sanger
David C. Marsh
Andrew Worster
Lehana Thabane
Zainab Samaan
机构
[1] McMaster University,Department of Psychiatry and Behavioural Neurosciences
[2] McMaster University,Department of Health Research Methods, Evidence, and Impact
[3] McMaster University,Bachelor of Health Sciences
[4] McMaster University,Neurosciences Graduate Program
[5] McMaster University,Department of Family Medicine
[6] McMaster University,Michael G. DeGroote School of Medicine
[7] McMaster University,Medical Sciences Graduate Program
[8] Northern Ontario School of Medicine,Department of Medicine
[9] Canadian Addiction Treatment Centres,Biostatistics Unit
[10] ICES North,Departments of Pediatrics/Anesthesia
[11] Health Sciences North Research Institute,undefined
[12] McMaster University,undefined
[13] Research Institute at St Joseph’s Healthcare,undefined
[14] McMaster University,undefined
来源
关键词
Marijuana; Cannabis; Opioid; Polysubstance use; Harm reduction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality
    Watts, Bradley, V
    Gottlieb, Daniel J.
    Riblet, Natalie B.
    Gui, Jiang
    Shiner, Brian
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (04): : 298 - 304
  • [22] Association of Pregnancy and Insurance Status with Treatment for Opioid Use Disorder
    Fernandes, Karen
    OBSTETRICS AND GYNECOLOGY, 2021, 137 (05): : 957 - 957
  • [23] Use of telemedicine for opioid use disorder treatment - Perceptions and experiences of opioid use disorder clinicians
    Riedel, Lauren
    Uscher-Pines, Lori
    Mehrotra, Ateev
    Busch, Alisa B.
    Barnett, Michael L.
    Raja, Pushpa
    Huskamp, Haiden A.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 228
  • [24] The Use of Oxytocin for the Treatment of Opioid Use Disorder
    Edinoff, Amber N.
    Sall, Saveen
    Honore, Lauryn G.
    Dies, Ross M.
    Zaheri, Alexa R.
    Kataria, Saurabh
    Jackson, Eric D.
    Shekoohi, Sahar
    Cornett, Elyse M.
    Murnane, Kevin S.
    Kaye, Adam M.
    Kaye, Alan D.
    CURRENT PAIN AND HEADACHE REPORTS, 2023, 27 (5) : 89 - 97
  • [25] The Use of Oxytocin for the Treatment of Opioid Use Disorder
    Amber N. Edinoff
    Saveen Sall
    Lauryn G. Honore
    Ross M. Dies
    Alexa R. Zaheri
    Saurabh Kataria
    Eric D. Jackson
    Sahar Shekoohi
    Elyse M. Cornett
    Kevin S. Murnane
    Adam M. Kaye
    Alan D. Kaye
    Current Pain and Headache Reports, 2023, 27 : 89 - 97
  • [26] Emerging Evidence for Cannabis' Role in Opioid Use Disorder
    Wiese, Beth
    Wilson-Poe, Adrianne R.
    CANNABIS AND CANNABINOID RESEARCH, 2018, 3 (01) : 179 - 189
  • [27] Cannabis use and cannabis use disorder
    Jason P. Connor
    Daniel Stjepanović
    Bernard Le Foll
    Eva Hoch
    Alan J. Budney
    Wayne D. Hall
    Nature Reviews Disease Primers, 7
  • [28] Cannabis use and cannabis use disorder
    Connor, Jason P.
    Stjepanovic, Daniel
    Le Foll, Bernard
    Hoch, Eva
    Budney, Alan J.
    Hall, Wayne D.
    NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [30] Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study
    Hillmer, Alannah
    Chawar, Caroul
    Lamri, Amel
    Hudson, Jacqueline
    Kapczinski, Flavio
    Minuzzi, Luciano
    Marsh, David C.
    Thabane, Lehana
    Paterson, Andrew D.
    Samaan, Zainab
    PLOS ONE, 2023, 18 (07):